Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does CABOZANTINIB S-MALATE Cause Hypothyroidism? 724 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 724 reports of Hypothyroidism have been filed in association with CABOZANTINIB S-MALATE (CABOMETYX). This represents 1.8% of all adverse event reports for CABOZANTINIB S-MALATE.

724
Reports of Hypothyroidism with CABOZANTINIB S-MALATE
1.8%
of all CABOZANTINIB S-MALATE reports
49
Deaths
128
Hospitalizations

How Dangerous Is Hypothyroidism From CABOZANTINIB S-MALATE?

Of the 724 reports, 49 (6.8%) resulted in death, 128 (17.7%) required hospitalization, and 16 (2.2%) were considered life-threatening.

Is Hypothyroidism Listed in the Official Label?

Yes, Hypothyroidism is listed as a known adverse reaction in the official FDA drug label for CABOZANTINIB S-MALATE.

What Other Side Effects Does CABOZANTINIB S-MALATE Cause?

Diarrhoea (8,282) Fatigue (6,819) Off label use (5,245) Nausea (4,341) Decreased appetite (4,076) Blood pressure increased (2,939) Malignant neoplasm progression (2,718) Palmar-plantar erythrodysaesthesia syndrome (2,706) Weight decreased (2,657) Stomatitis (2,560)

What Other Drugs Cause Hypothyroidism?

PEMBROLIZUMAB (2,326) LEVOTHYROXINE (2,107) NIVOLUMAB (1,939) LENVATINIB (1,375) ATEZOLIZUMAB (881) ALBUTEROL (877) CARBOPLATIN (830) IPILIMUMAB (770) AMIODARONE (764) PREDNISONE (739)

Which CABOZANTINIB S-MALATE Alternatives Have Lower Hypothyroidism Risk?

CABOZANTINIB S-MALATE vs CAFFEINE CABOZANTINIB S-MALATE vs CALASPARGASE PEGOL CABOZANTINIB S-MALATE vs CALASPARGASE PEGOL-MKNL CABOZANTINIB S-MALATE vs CALCIFEDIOL CABOZANTINIB S-MALATE vs CALCIPOTRIENE

Related Pages

CABOZANTINIB S-MALATE Full Profile All Hypothyroidism Reports All Drugs Causing Hypothyroidism CABOZANTINIB S-MALATE Demographics